ArticleTherapeutic advances in endocrinology and metabolism2026
Analysis of risk factors and establishment of a prediction model for latent autoimmune diabetes in adults.
Article in Therapeutic advances in endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Explainable machine learning model for in-hospital hypoglycemia risk in patients with latent autoimmune diabetes in adults.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Latent autoimmune diabetes in adults (LADA) is a form of diabetes that shares clinical features with type 2 diabetes mellitus (T2DM), often leading to misdiagnosis and delayed treatment. Early detection is critical to prevent the progression of the disease. Objectives: This study aims to analyze the risk factors of LADA and develop a predictive model to enhance early diagnosis. Design: A retrospective study was conducted on T2DM patients treated at our hospital between June 2019 and June 2024. The study focused on identifying risk factors for LADA and developing a predictive model. Data sources and methods: Clinical data of 728 patients (651 non-LADA, 77 LADA) were analyzed. LASSO regression was used for variable selection, followed by logistic regression to identify risk factors. The model's performance was assessed using the receiver operating characteristic curve and the Hosmer-Lemeshow test. Results: Significant differences were found between the non-LADA and LADA groups in terms of thyroid disease history, diabetic ketoacidosis, fasting plasma glucose (FPG), 2-hour postprandial glucose (2hPG), and glycated hemoglobin (HbA1c) levels ( Conclusion: The predictive model based on thyroid disease history, FPG, 2hPG, and HbA1c demonstrates excellent predictive ability in our cohort for early identification of LADA, suggesting its potential to aid in timely intervention and improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.